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ABSTRACT
 
Aims
 
To describe the volume of  alcohol consumption and patterns of  drinking in the World Health Organization
(WHO) European regions in 2002 and to estimate quantitatively the burden of  disease attributable to alcohol in that
year. 
 
Methods
 
Secondary data analysis. Exposure data were taken from the WHO Comparative Risk Assessment, out-
come data from the WHO Measurement and Health Information department, and used to derive three outcome mea-
sures: deaths, years of  life lost (YLL) and disability adjusted life years (DALY) for 2002. All calculations were conducted
according to age, sex and region. 
 
Results
 
Alcohol consumption in the WHO regions for Europe was high, with 12.1
litres pure alcohol per capita, on average more than 100% above the global consumption. Alcohol consumption caused
a considerable disease burden: 6.1% of  all the deaths, 12.3% of  all YLL and 10.7% of  all DALY in all European regions
in 2002 could be attributed to this exposure. Intentional and unintentional injuries accounted for almost 50% of  all
alcohol-attributable deaths and almost 44% of  alcohol-attributable disease burden. Young people and men were
affected the most. Geographically, the most eastern region around Russia had the highest alcohol-attributable disease
burden. 
 
Conclusions
 
Interventions should be implemented to reduce the high burden of  alcohol-attributable disease
in the European regions. Given the epidemiological structure of  the burden, injury prevention, including but not
restricted to the prevention of  traffic injuries, and specific prevention for young people should play the most important
role in a comprehensive plan to reduce alcohol-attributable burden.
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INTRODUCTION
 
Alcohol is one of  the major risk factors for burden of  dis-
ease and social harm for both developed and developing
countries [1–4]. The objective of  this paper is to describe
the volume of  alcohol consumption and pattern of  drink-
ing specifically for Europe, to estimate quantitatively the
disease burden attributable to alcohol for the different
World Health Organization (WHO) European regions,
and to derive general implications of  the epidemiological
situation for public health and alcohol policy. Findings
will be based on new WHO burden of  disease estimates for
2002 and the results of  the Comparative Risk Assessment
(CRA) of  WHO, which was part of  the Global Burden of
Disease (GBD) 2000 study (for results for the CRA see
[2,4,5]; for a more general description of  GBD see [6,7]).
The CRA was a landmark study that focused on causal
attribution of  disease to selected risk factors in order to
evaluate how changes in population health and risk
exposure would affect major disease outcomes. As the
CRA restricted itself  to disease burden, the burden esti-
mates presented here exclude social harm other than the
intentional injury categories captured by the 
 
Interna-
tional Classification of  Diseases
 
 (for an overview of  ICD cat-
egories where alcohol is causally related see [8,9]).
Two dimensions of  alcohol were considered: average
volume of  alcohol consumption and patterns of  drinking
(for details see [4,10,11]). Patterns of  drinking were oper-
ationalized by a riskiness score of  cultural drinking pat-
tern derived from multiple indicators of  heavy drinking
occasions (e.g. frequency of  intoxication, average quan-
tity per drinking occasion, level of  festive drinking), and
one indicator each for drinking with meals and drinking
in public places. These patterns were found to load onto
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one dimension and were linked to burden of  ischaemic
heart disease and injury [4,10]. Average volume and pat-
terns of  drinking had to be separated as different dimen-
sions, as it has been shown that each can influence
burden of  disease as well as social harm (see also [8,12])
independently of  the other. Both dimensions of  alcohol
consumption were estimated on the country level and
then aggregated to WHO regions [4,11]. The burden of
various disease outcomes were estimated at the regional
level based on epidemiological research on risk relations
between average volume of  alcohol consumption, pat-
terns of  drinking and different disease and injury catego-
ries [4,8].
 
MATERIALS AND METHODS
 
Definition of  regions
 
The regional distribution used in this study was defined
by the WHO [13] on the basis of  high, low or very low lev-
els of  adult and of  infant mortality. The relevant regions
for Europe are displayed in Table 1.
The regional groups are organized as follows: A 
 
=
 
 low
child and very low adult mortality, B 
 
=
 
 low child and low
adult mortality, C 
 
=
 
 low child and high adult mortality,
D 
 
=
 
 high child and high adult mortality and E 
 
=
 
 very high
child and very high adult mortality [13]. As indicated in
Table 1, only categories A, B and C are relevant.
 
Exposure estimates
 
The exact procedures used to estimate exposure to alco-
hol are described in detail elsewhere [4,10,11]. As men-
tioned, two dimensions of  alcohol relevant for disease
were included: average volume of  alcohol consumption
and a summary score for patterns of  drinking. Although
the usual method to assess alcohol consumption is over-
all volume, it is also important to take into account how
this alcohol is consumed (in this case, the average pattern
of  consumption for countries and regions). This means
that the impact of  average volume of  consumption on
mortality or morbidity is moderated partly by the way
alcohol is consumed by individuals. Past studies have
linked detrimental patterns of  drinking with both acute
and chronic diseases, specifically ischaemic heart disease
and cardiac death [14–17]; for an overview see [18].
In brief, the prevalence of  average volume of  alcohol
consumption was estimated in four sex-specific drinking
categories by age and country and measured in grams of
pure alcohol per day (defined as: abstainer, drinking cat-
egory I: women 
 
>
 
 0 to 
 
<
 
 20 g; men 
 
>
 
 0 to 
 
<
 
 40 g; drinking
category II: women 20 to 
 
<
 
 40 g; men 40 to 
 
<
 
 60 g; drink-
ing category III: women 
 
>
 
 40 g; men 
 
>
 
 60 g). These prev-
alence rates were estimated using a triangulation of
country-specific adult per capita data and general popu-
lation survey results [4,10,11], taken mainly from the
Global Alcohol Database (http://www.who.int/alcohol).
A score reflecting riskiness of  cultural drinking pattern
was calculated for each country using triangulation of
general population results and key informant surveys
relating to the extent that alcohol was consumed in
heavy drinking occasions, without meals and in public
places [4,10,11]. Uncertainty of  the estimates for each
dimension was also quantified [3], consistent with the
general approach of  the Global Burden of  Disease 2000
study (http://www3.who.int/whosis/discussion_papers/
pdf/paper36.pdf).
 
Outcome categories and estimates
 
Both event and gap measures were considered: mortality,
as measured in number of  deaths, was the event measure;
years of  life lost due to premature mortality (YLL) and
burden of  disease, as measured in disability adjusted life
years (DALY), constituted the gap measures. The DALY
measure combines YLL with years of  life lived in disability
into a summary measure (for general definitions see [6].
To give an example: if  a male dies at age 40, one would
 
Table 1
 
Classification of  countries in World Health Organization European regions by childhood and adult mortality [13].
 
Europe A:
very low childhood and very low adult mortality
Europe B:
low childhood and low adult mortality
Europe C:
high childhood and low adult mortality
 
Andorra, Austria, Belgium, Croatia, Czech
Republic, Denmark, Finland, France,
Germany, Greece, Iceland, Ireland, Israel,
Italy, Luxembourg, Malta, Monaco, the
Netherlands, Norway, Portugal, San
Marino, Slovenia, Spain, Sweden,
Switzerland, United Kingdom
Albania, Armenia,* Azerbaijan,*
Bosnia and Herzegovina,
Bulgaria, Georgia, Kyrgyzstan,*
Poland, Romania, Slovakia, the
Former Yugoslav Republic of
Macedonia, Tajikistan,*
Turkmenistan,* Turkey,
Uzbekistan,* Yugoslavia
Belarus, Estonia, Hungary,
Kazakhstan, Latvia, Lithuania,
Republic of  Moldova, Russian
Federation, Ukraine
 
Definition of  regions: the regional subgroupings used were defined by WHO in the World Health Report 2000 [13] on the basis of  high, medium or low
levels of  adult and of  infant mortality. *Countries marked with 
 
* 
 
in Europe B are classified as B 2 in Table 2; the rest of  the countries in this category are
in Europe B 1.
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assign the number of  years up to his expected life expect-
ancy as DALY lost where, for reasons of  comparability, the
life expectancy of  Japan was used (80 years for men and
82.5 years for women). Similarly, if  a person had an acci-
dent and would be paraplegic for the rest of  his life, he
would lose 0.5 DALYS per year, based on the specific dis-
ability weight for this disease. Estimates for mortality and
DALY for 2002 were obtained directly by WHO Head-
quarters (Dr C. Mathers). YLL and DALY were discounted
and age-weighted to be comparable with the GBD study.
Outcome categories followed the definitions used in
the CRA and were defined to be consistent across several
risk factors [2,3,19]. They corresponded to the categories
used for the GBD 2000 study [7,19]. GBD 2000 catego-
ries of  disease used were broader than ICD codes.
 
Risk relations
 
Alcohol consumption was found to be related to the fol-
lowing GBD categories [4,7,8]: low birth weight, mouth
and oropharyngeal cancer, oesophageal cancer, liver
cancer, breast cancer, unipolar major depression, epi-
lepsy, alcohol use disorders, hypertensive disorders,
ischaemic heart disease (IHD), cerebrovascular disease,
diabetes mellitus, cirrhosis of  the liver, motor vehicle acci-
dents, drownings, falls, poisonings, self-inflicted injuries
and homicide.
Details of  the procedures to quantify the risk of  disease
attributable to alcohol are described elsewhere [4,8,9]. In
general, for most chronic disease categories, alcohol-
attributable fractions (AAFs) of  disease were derived from
combining prevalence and relative risk estimates based
on meta-analyses [8,9,20–22] using the following for-
mula [23,24]:
AF 
 
=
 
 [
 
Σ
 
k
i
 
=
 
1
 
 
 
P
 
i
 
(
 
RR
 
i
 
 
 
−
 
 1)]/[
 
Σ
 
k
i
 
=
 
0
 
 
 
P
 
i
 
(
 
RR
 
i
 
 
 
−
 
 1) 
 
+
 
 1]
where 
 
i
 
: exposure category with baseline exposure or no
exposure 
 
i
 
 
 
=
 
 0; 
 
RR
 
i
 
: relative risk at exposure level 
 
i
 
 com-
pared to no consumption; 
 
P
 
i
 
: prevalence of  the 
 
i
 
-th cate-
gory of  exposure.
AAFs thus derived can be interpreted as reflecting the
proportion of  disease that would disappear if  there had
been no alcohol consumption.
For depression, AAFs were derived from mental health
surveys, taking into consideration the rates of  comorbid-
ity and time of  onset for both conditions (alcohol use dis-
orders, depression) compared to other mental diseases
comorbid with alcohol [4]. For IHD, the interaction of
average volume and patterns of  drinking was modelled
using multi-level analyses (for methods see: [4,25]; for
results: [4,26]. This multi-level modelling was based on
country-specific time-series of  both disease rates and per
capita consumption and modelled IHD disease rates by
sex, using patterns of  drinking as a mediating variable for
per capita consumption, and controlling for year and
gross domestic product. The multi-level approach was
chosen after a methodological study on different statisti-
cal approaches to model these relationships [25]. For the
final estimates relating to IHD, AAFs were based on these
multi-level results for all countries except for the Europe
A region with relatively favourable drinking patterns (see
[4]). For Europe A, results of  a meta-analysis were used
[27]. For injuries, a multi-level methodological approach
was taken to quantify the interaction of  average volume
of  consumption and patterns of  drinking in determining
AAFs [4].
 
RESULTS
 
Country-level indicators of  alcohol exposure and eco-
nomic development are described in detail elsewhere [4].
Per capita adult consumption, including unrecorded con-
sumption, varied 10-fold in European countries, from
2.9 litres (Uzbekistan) to almost 30 litres of  pure alcohol
(Republic of  Moldova). The population-weighted average
value in the WHO European regions was 12.1 litres,
more than twice the global adult per capita consumption
of  5.8 litres (see also Table 2). Overall, average volume of
alcohol consumption in the European region broadly fol-
lowed the WHO region categories:
• Western European countries and most EU countries are
in Europe A, with an average consumption of  12.9
litres adult per capita consumption. The Nordic coun-
tries tended to have an average adult per capita con-
sumption that was a little lower.
• Europe B can be divided into two different subregions.
Europe B1 would consist of  the southernmost of  the
former Socialist republics bordering Asia. Their con-
sumption was relatively low (4.3 litres per capita),
partly because of  the strong influence of  the Islamic
religion. Europe B2 would be the Central and Eastern
European countries of  the former Socialist republics
which have a relatively high gross national product
(GNP) (and, thus, their mortality rates are lower than
the rates in Russia and other countries with lower
GNP). These countries have a relatively high consump-
tion overall compared to the global average (9.3 litres
per capita), but lower than both the western European
countries or Russia and its surrounding countries
(Europe C).
• Russia and the surrounding countries in the East of
Europe comprise Europe C. These countries can be
characterized by a very high per capita consumption
(13.9 litres adult per capita consumption), which was
the highest of  all WHO regions around the world (see
[12]) for a comparative table).
There was also divergence in drinking patterns
between regions. Whereas Europe A overall showed the
least detrimental patterns (with the exception of  the
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Nordic countries), all other regions had overall more
harmful patterns, with Russia and the other countries of
Europe C displaying the most detrimental patterns. Given
the high adult per capita values, it is not surprising that
the majority of  males and females consume alcohol. The
only exception is the region made up of  the southernmost
former Socialist republics under Islamic influence, where
only one-third of  the females drink.
Overall, alcohol consumption in Europe is high in all
regions, and is combined with a detrimental drinking pat-
tern in all countries except for the wealthiest part of  the
West and the Mediterranean region. For some countries
in this region, more recent data suggest a more detrimen-
tal drinking pattern as well, especially in the young [28].
Alcohol consumption caused a considerable disease
burden; 6.1% of  all the deaths, 12.3% of  all YLL and
10.7% of  all DALY in Europe in 2002 could be attributed
to this exposure, with most of  the burden in Europe C (see
Tables 3–5). The alcohol-attributable burden of  disease in
Europe C is the highest of  all the WHO regions world-wide
(see [4,29]). In addition, it seems to have increased
slightly from 2000 (estimates for 2000: 5.5% of  all deaths
and 10.2% of  all DALY).
In all regions, males had considerably higher mortal-
ity, disease burden and YLL than females. This reflects the
fact, that in all countries, surveys indicated that males
consumed the majority of  alcohol, and also had far more
heavy drinking compared to females. Injury, especially
unintentional injury, was the category which accounted
for most deaths (49.9%) and YLL (60.3%) and a consid-
erable burden of  disease (43.7%) in Europe, i.e. Europe A,
B and C combined. The second most important contribu-
tor to burden of  disease were the neuropsychiatric disor-
ders (32.3%), a category made up almost entirely of
alcohol  use  disorders.  With  regard  to  the  proportion
of  neuropsychiatric disorders, the difference between
deaths, YLL and DALY is due to the fact that alcohol use
disorders cause high disability but are not necessarily
lethal. The high level of  alcohol use disorders in Europe
was confirmed recently by a pooled analyses where differ-
ent studies in many European Union countries showed
consistently high rates of  alcohol use disorders ([30]; see
also [12]).
In terms of  vascular diseases, an overall protective
effect was predicted for ischaemic heart disease (the most
important category) for Europe A because of  its more
favourable drinking pattern, i.e. relatively regular drink-
ing without too many heavy drinking occasions. This
pattern of  drinking has been linked to protective effects
on ischaemic diseases [14,31], and in individual-level
European cohorts with regular drinking patterns, the
cardioprotective effect has been confirmed (e.g. see liter-
ature cited in [9,20]. It should be noted that most aggre-
gate-level studies failed to corroborate this effect (for an
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overview see [31]). In all other European regions, the
overall impact of  alcohol consumption on vascular dis-
ease was estimated to cause a substantial amount of  vas-
cular disease, as predicted by the different biochemical
processes related to irregular heavy drinking [31,32].
There is also recent epidemiological research confirming
these estimates (e.g. [18,33,34]).
Tables 6 and 7 summarize the key gender and age dis-
tributions about alcohol-attributable deaths in Europe. It
becomes clear that, contrary to most other risk factors for
developed countries such as tobacco, hypertension or
high cholesterol, alcohol impacts health detrimentally
relatively early in life [2,3,30]. Conversely, the protective
effects on IHD and other vascular disease occur later in
life (see Table 6).
Table 7 shows the relative proportion of  alcohol-
attributable deaths to all deaths by gender and age. This
proportion is highest in all regions and for both genders
in the age group 15–29 years (with a small exception for
females in Europe B). In other words, in young adulthood
alcohol was the most important risk factor. This is also
the age period when no protective effects can be seen (see
recent meta-analyses on alcohol and all-cause mortality
[35,36]).
 
Table 3
 
Alcohol-attributable deaths (000s) in 2002 by disease and region (own calculations).
 
Region WHO classification Sex*
WHO Europe region
% of  all alcohol-
attributable deaths
Total
A B C
A, B and C
TotalM F M F M F
 
Maternal and perinatal conditions 0 0 0 0 0 0 0 0.06
Cancer 29 21 6 4 15 9 84 14.5
Neuropsychiatric conditions 12 4 4 1 11 3 35 6.0
Vascular conditions
 
−
 
34
 
−
 
117 47 11 129 40 76 13.1
Other non-communicable diseases 26 9 12 6 29 14 95 16.4
Unintentional injury 26 8 21 3 128 21 207 35.6
Intentional injury 7 2 7 1 57 10 83 14.3
All alcohol-attributable deaths 66
 
−
 
74 98 25 370 96 581 100.0
All deaths in the region 1950 1970 993 872 1987 1792 9564
% alcohol-attributable of  all deaths 3.4
 
−
 
3.8 9.9 2.9 18.6 5.4 6.1
 
*M 
 
=
 
 male, F 
 
=
 
 female. Numbers are rounded to full thousands, i.e. 0 indicates that there are less than 500 alcohol-attributable deaths in the respective
category.
 
Table 4
 
Alcohol-attributable potential years of  life lost (YLL) (000s) in 2002 by disease category and region (own calculations).
 
Region WHO classification
Sex*
World Health Organization Europe region
% of  all alcohol-
attributable YLL
Total
A B C
A, B and C
TotalM F M F M F
 
Maternal and perinatal
conditions
1 1 4 3 2 1 12 0.1
Cancer 279 180 74 42 176 97 847 8.4
Neuropsychiatric conditions 186 54 75 19 207 48 589 5.8
Vascular conditions 227
 
−
 
494 416 86 1 192 253 1 226 12.1
Other non-communicable
diseases
332 121 176 77 454 195 1 355 13.4
Unintentional injury 510 91 489 57 2 727 397 4 271 42.2
Intentional injury 143 37 157 22 1 276 196 1 830 18.1
All alcohol-attributable YLL 1 224
 
−
 
11 1 390 306 6 032 1 187 10 128 100
All YLL in the region 14 133 9830 11 891 8303 24 996 13 490 82 644
% alcohol-attributable of  all
YLL
8.7
 
−
 
0.1 11.7 3.7 24.1 8.8 12.3
 
*M 
 
=
 
 male, F 
 
=
 
 female. YLL were calculated based on standard age weights and a discount rate of  0.03 for each year lost. Numbers are rounded to full
thousands. e.g. 0 indicates that there are less than 500 alcohol-attributable YLL in the respective category.
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Table 8 compares the impact of  alcohol with other risk
factors. Overall in the European regions, alcohol is the
third most important risk factor for burden of  disease,
surpassed only by hypertension (most important) and
tobacco. In the region with the most alcohol-attributable
health harm, Europe C, it is second only to hypertension.
 
DISCUSSION
 
Although alcohol is a major risk factor in several regions
of  the world, Europe has the highest alcohol-attributable
burden of  disease. Prevention of  alcohol-attributable
harm should then be a major public health priority in this
region (see also [37]). Before discussing potential strate-
gies for prevention, however, the strengths and limita-
tions of  the estimates presented should be examined.
Clearly, the strength of  this analysis is the standardized
methodology developed originally for the CRA, as well as
the use of  official mortality and morbidity statistics (for
general methodology to derive these statistics, see [7]).
The resulting comparability between risk factors differen-
tiates CRA-based risk factor analyses from other risk fac-
tor estimates, including the estimates of  the 1990 Global
Burden of  Disease Study, where results could not be com-
pared between risk factors [38].
On the negative side, global and regional alcohol-
attributable burden of  disease estimates based on the
CRA methodology have some limitations, in that they
 
Table 5
 
Alcohol-attributable disease burden in DALY (000 s) in 2002 by disease category and region (own calculations).
 
Region WHO classification
Sex*
World Health Organization Europe region
% of  all alcohol-
attributable DALY
Total
A B C
A, B and C
TotalM F M F M F
 
Maternal and perinatal
conditions
2 1 4 3 2 1 14 0.1
Cancer 288 203 75 45 179 102 893 5.5
Neuropsychiatric
conditions
1 983 494 608 108 1 658 355 5 205 32.3
Vascular conditions
 
−
 
185
 
−
 
664 466 101 1 309 281 1 309 8.1
Other non-
communicable
diseases
389 142 218 102 546 251 1 648 10.2
Unintentional injury 625 135 641 80 3 067 473 5 021 31.2
Intentional injury 150 41 169 25 1 405 226 2 014 12.5
All alcohol-attributable
DALY
3 252 352 2 181 464 8 166 1 689 16 105 100.0
All DALY in the region 27 329 24 396 20 302 17 395 36 250 24 650 150 322
% alcohol-attributable of
all DALY
11.9 1.4 10.7 2.7 22.5 6.9 10.7
 
*M 
 
=
 
 male,  F 
 
=
 
 female.  Numbers are rounded to full  thousands. e.g.  0 indicates that there are less than 500 alcohol-attributable DALY in the respective
category.
 
Table 6
 
Age and sex distribution among alcohol-attributable
deaths in World Health Organization Europe regions for 2002
(own calculations).
 
Europe A Europe B Europe C
 
Males
0–4 0.3% 0.5% 0.2%
5–14 0.4% 0.5% 0.2%
15–29 13.5% 10.2% 11.0%
30–44 22.4% 14.3% 20.7%
45–59 36.5% 22.8% 29.0%
60–69 21.4% 21.1% 19.7%
70–79 6.6% 21.1% 13.7%
80
 
+
 
–
 
1.0% 9.6% 5.5%
Total deaths
in 1000
66 98 370
Females
0–4
5–14
15–29
Not meaningful, as
there was a net
beneficial effect,
0.8%
0.4%
5.3%
0.2%
0.2%
5.8%
30–44
45–59
60–69
but there were no
net gains before
age 70
10.3%
20.8%
19.6%
11.8%
22.7%
18.0%
70–79 25.4% 22.0%
80
 
+
 
17.3% 19.4%
Total deaths
in 1000
 
−
 
74 25 96
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require a number of  assumptions to be made. The most
crucial assumptions for alcohol-attributable burden of
disease are as follows:
• estimates of  per capita consumption and unrecorded
consumption for different countries do not contain
substantial measurement error;
• the distribution of  consumption as derived from sur-
veys is similar to the real distribution in the population;
and
• alcohol–chronic disease relationships, as derived from
meta-analyses of  cohort and case–control studies, are
stable between countries and regions and for different
age groups.
There is some evidence that per capita consumption can
be estimated reliably, and per capita information is avail-
able for the vast majority of  countries (see above and
[4,11]. However, most of  the sources on per capita
information are restricted to recorded consumption.
When it comes to unrecorded consumption, there is sub-
stantial measurement error, making the estimates given
here most problematic for those regions where unre-
corded consumption constitutes a considerable portion of
total alcohol, i.e. Europe B and C. With respect to survey
information, we have the long-known problem of  under-
coverage [39,40], as most surveys cover only 60% or less
of  the per capita consumption. However, as the average
volume per capita was based on production and/or sales
estimates, the measure of  volume of  drinking overall can
be perceived as relatively reliable [40].
This leaves the stability of  alcohol–chronic disease
relationships as the most crucial part of  the estimates dis-
played above. There are some indications that the relative
risks for countries outside the most developed countries
(i.e. Europe A, North America, Japan, Australia) may not
 
Table 7
 
Proportion of  alcohol-attributable deaths among all deaths in World Health Organization Europe regions among people
aged less than 70 years for 2002 (own calculations).
 
Age in years
0–4 5–14 15–29 30–44 45–59 60–69
 
Europe A
Males
Alcohol-attributable deaths 
 
n
 
171 247 8 931 14 832 24 141 14 180
All deaths 
 
n
 
12 765 3 487 33 435 76 981 228 911 347 525
Proportion of  alcohol-
attributable deaths
1.3% 7.1% 26.7% 19.3% 10.5% 4.1%
Females
Alcohol-attributable deaths 
 
n
 
82 87 1 175 3 224 7 630 528
All deaths 
 
n
 
9 950 2 520 11 407 36 856 117 665 185 054
Proportion of  alcohol-
attributable deaths
0.8% 3.5% 10.3% 8.7% 6.5% 0.3%
Europe B
Males
Alcohol-attributable deaths 453 459 9 968 13 997 22 250 20 574
All deaths 66 834 11 344 40 949 72 825 167 880 213 655
Proportion of  alcohol-
attributable deaths
0.7% 4.0% 23.1% 18.5% 13.0% 9.6%
Females
Alcohol-attributable deaths 208 102 1 344 2 598 5 243 4 946
All deaths 55 555 7 613 17 989 35 513 84 633 138 176
Proportion of  alcohol-
attributable deaths
0.4% 1.3% 7.5% 7.3% 6.2% 3.6%
Europe C
Males
Alcohol-attributable deaths 640 808 40 807 76 545 107 438 72 771
All deaths 25 692 8 449 100 406 249 401 476 815 484 263
Proportion of  alcohol-
attributable deaths
2.5% 9.6% 40.6% 30.7% 22.5% 15.0%
Females
Alcohol-attributable deaths 190 196 5 545 11 277 21 779 17 247
All deaths 18 571 4 886 26 900 71 285 181 563 288 863
Proportion of  alcohol-
attributable deaths
1.0% 4.0% 20.6% 15.8% 12.0% 6.0%
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be the same as in these countries [19]. Thus, the esti-
mates of  the CRA may turn out to be biased. However,
some newer direct assessment epidemiological results in
Russia and other countries of  Europe C appear to be sim-
ilar to the results indicated above [18,33,34]. In addition,
there is some suggestion that the approximations used
have been underestimated rather than overestimated due
to the general shift in chronic disease and injury and due
to the fact that the detrimental effect of  alcohol seem to be
more pronounced in interaction with poverty and mal-
nutrition [41]. However, this is true only for age groups
under age 70 years. For age groups above this age, we
probably overestimate the effects of  alcohol, as there is
good evidence that relative risks converge to 1 in these
age groups [42]. Moreover, for these age groups we have
the problem of  more unreliable death certificates [42].
The problem is present for both detrimental and benefi-
cial health outcomes, but it should be noted that the
majority of  the beneficial effects occur in old age [42].
In any case, disease is only part of  the burden related
to alcohol. In some countries, the alcohol-attributable
disease burden was actually less when compared to the
social harm caused by alcohol [43]. Thus, effective alco-
hol policy and other interventions aiming to reduce alco-
hol-attributable disease burden may have additional side
effects  on  reducing  social  harm  [44].  Such  measures
to reduce alcohol-attributable burden are available
[12,37,44–46] and for the European regions, given their
epidemiological situation, four types of  interventions
should be given special attention:
 
Table 8
 
Leading risk factors for disease burden in the different World Health Organization Europe regions in percentage of  overall
DALY for 2000 [3,19].
 
Europe A Europe B Europe C
All Total
(000) Rank
Males
(000)
Females
(000)
Males
(000)
Females
(000)
 
Females
(000)
 
Males
(000)
 
Childhood and maternal undernutrition
Underweight 10 9 367 324 32 29 771 15
Iron deficiency 87 211 166 271 110 161 1 006 11
Vitamin A deficiency 0 0 1 1 0 0 2 26
Zinc deficiency 0 0 65 56 5 4 130 23
Other diet-related risks and physical inactivity
Blood pressure 2624 1828 2699 2180 5386 4632 19 349 1
Cholesterol 2062 1317 1461 996 4109 3211 13 156 4
Overweight 1922 1735 1420 1445 2578 2684 11 784 5
Low fruit and vegetable intake 785 413 777 511 2431 1684 6 601 6
Physical inactivity 852 654 636 494 1461 1236 5 333 7
Sexual and reproductive health risks
Unsafe sex 114 202 50 240 134 295 1 035 10
Lack of  contraception – 3 – 83 – 47 133 22
Addictive substances
Tobacco 4991 1464 3381 715 7230 832 18 613 2
Alcohol 3103 416 2183 446 7543 1570 15 261 3
Illicit drugs 764 365 179 82 717 225 2 332 8
Environmental risks
Unsafe water, sanitation and hygiene 33 33 287 262 64 57 736 16
Urban air pollution 91 60 197 141 217 153 859 13
Indoor smoke from solid fuels 0 0 233 244 18 49 544 17
Lead exposure 75 43 304 189 424 211 1 246 9
Climate change 1 2 5 5 2 2 17 25
Occupational risks
Risk factors for injury 180 22 243 19 495 41 1 000 12
Carcinogens 131 21 82 12 166 31 443 19
Airborne particulates 140 42 79 6 132 10 409 20
Ergonomic stressors 21 11 18 12 21 14 97 24
Noise 117 47 92 50 136 92 534 18
Other selected risks to health
Unsafe health care injections 0 0 8 5 106 59 178 21
Childhood sexual abuse 61 175 72 158 132 205 803 14
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• The primary focus should be injury prevention includ-
ing, but not limited to, those interventions that reduce
alcohol-attributable traffic harm (i.e. 
 
per se
 
 laws on low
levels of  blood alcohol concentration in traffic with
strict enforcement via random breath testing, admin-
istrative licence suspension, graduated licensing for
novice drivers; see [12]).
• The overall volume of  consumption should be reduced.
Different interventions are available to achieve this
goal, with taxation being one of  the most successful
and cost-effective measures [12,45], especially in
young adults.
• Irregular heavy drinking should be reduced. Brief  inter-
ventions have been shown to achieve this goal, but over-
all there few proven interventions to change patterns of
drinking [12]. With brief  interventions, however, the
high burden of  alcohol use disorders could be reduced.
• Specific interventions need to address alcohol-attribut-
able harm in adolescence and young adulthood. This
could include mandatory identification for age verifica-
tion in both on- and off-licensed establishments [12].
Overall, there is a need for international, national and
community leaders to plan effective changes that will
reduce burden of  disease and social harm related to alco-
hol. Initiative in this direction has begun under the
umbrella of  WHO Europe with the proposed new frame-
work for alcohol policy in the WHO European Region
(http://www.euro.who.int/Governance/RC/RC55/
20050609-9), but it is up to the responsible national and
international policy makers to implement these mea-
sures. Without these policy changes, given the patterns of
disease related to alcohol, we expect further increases of
alcohol-attributable disease burden in the European
regions, even if  the current levels of  consumption do not
increase [4].
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